Repeated hypoglycaemia may be detrimental to cognitive functions in the diabetic patient;Risque cognitif des hypoglycemies repetees chez le diabetique

Diabetes and Metabolism

Volumn 24, Issue 2, 1998, Pages 167-172

  Selam, J L ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

COGNITIVE DEFECT; DIABETES MELLITUS; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; NOTE; RECURRENT DISEASE; CHRONIC DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR;

CHRONIC DISEASE; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; RECURRENCE; RISK FACTORS;

EID: 0032041105     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (51)

1. Grimaldi A, Slama G, Tubiana-Rufi N, Heurtier A, Sélam JL, Scheen A, Sachon C, Vialettes B, Robert JJ, Perlemuter L. Hypoglycaemia of the diabetic patient. Diab Metab, 1997, 23, 100-108.
2. Amiel SA. Hypoglycaemia in diabetes mellitus - protecting the brain. Diabetologia, 1991, 40, (suppl.) 62-68.
3. Gold AE, Marshall SM. Cortical blindness and cerebral infarction associated with severe hypoglycemia. Diabetes Care, 1996, 19, 1001-03.
4. Gold AE, Deary IJ, Frier BM. Hypoglycaemia and non-cognitive aspects of psychological function in insulin-dependent (type I) diabetes mellitus (IDDM). Diabetic Medicine, 1997, 14, 111-118.
5. Gold AE, Deary IJ, Frier BM. Recurrent severe hypoglycaemia and cognitive function in type I diabetes. Diabetic Medicine, 1993, 10, 503-508.
6. Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving H. Evidence for diabetic encephalopathy. Diabetic Medicine, 1991, 8, 162-167.
7. Ryan C, Vega A, Drash A Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics, 1985, 75, 921-927.
8. Soltesz G. Hypoglycaemia in the diabetic child. Baillière's Clinical Endocrinology and metabolism, 1993, 7, 741-45.
9. Langan SJ, Deary LJ, Hepbrun DA, Frier BM. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia, 1991, 34, 337-344.
10. Lincoln NB, Faleiro RM, Kelly C, Kirk BA, Jeffcoate WJ. Effect of long-term glycemic control on cognitive function. Diabetes Care, 1996, 19, 656-58.
11. Ryan CM, Williams TM, Finegold DN, Orchard TJ. Cognitive dysfunction in adults with type I (insulin-dependent) diabetes mellitus of long duration : effects of recurrent hypoglycaemia and other chronic complications. Diabetologia, 1993, 36, 329-34.
12. Chabriat H, Sachon C, Levasseur M, Grimaldi A, Pappata S, Rougeont D, Masure MC, De Recondo A, Samson Y. Brain metabolism after recurrent insulin induced hypoglycaemic episodes a PET study. J Neurol Neurosurg Psychiatry, 1994, 57, 1360-1365.
13. Reichard P, Berglund A, Britz A, Levander S, Rosenquist U. Hypoglycaemic episodes during intensified insulin treatment : increased frequency but no effect cognitive function. Journal of Internal Medicine, 1991, 229, 9-16.
14. The Diabetes Control and Complications Trial Research Group: Effects of intensive diabetes therapy on neuropsychological function in adults in the diabetes control and complications trial. Ann Intern Med, 1996, 124, 379-388.
15. Marker JC, Cryer PE, Clutter WE. Attenuated glucose recovery from hypoglycemia in the elderly. Diabetes, 1992, 41, 671-78.
16. Cryer PE. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. Diabetes, 1992, 41, 255-60.
17. Amiel SE, Sherwin RS, Simonson DC, Tamborlane WV. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes, 1988, 37, 901-907.
18. Amiel SE, Tamborlane WV, Simonson DC, Sherwin RS. Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med, 1987, 316, 1376-83.
19. Lingenfelser T, Renn W, Sommerwerck U, Jung MF, Buettner UW, Zaiser-Kaschel H, Kashel R, Eggstein M, Jakober B. Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypoglycemia in IDDM patients. Diabetes, 1993, 42, 610-18.
20. Heller SR, Cryer PE. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans. Diabetes, 1991, 40, 223-26.
21. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia. Diabetes, 1993, 42, 1233-37.
22. Strachan MWJ, Frier BM, Deary IJ. Cognitive assessment in diabetes : the need for consensus. Diabetic Medicine, 1997, 14, 421-422.
23. Heller SR, McDonald IA. The measurement of cognitive function during acute hypoglycaemia : experimental limitations and their effect on the study of hyoglycaemia unawareness. Diabetic Medicine, 1996, 13, 607-615.
24. Evans ML, Lomas J, Pernet A, Hopkins D, Joseph S, Amiel SA. Cognitive dysfunction coincides with the onset of hypoglycaemia and only improves after glucose recovery. EASD 1996, Satellite Symposium, August 30-31, 1996, Bled, Slovenia.
25. Amiel SA, Pottinger RC, Archibald HR, Chusney G, Cunnah DTF, Prior PF, Gale EAM. Effect of antecedent glucose control on cerebral function during hypoglycemia. Diabetes Care, 1991, 14, 109-18.
26. Amiel SA, Simonson DC, Tamborlane WV, De Fronzo RA, Sherwin RS. Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans. Diabetes, 1987, 38, 518-22.
27. Maran A, Lomas J, McDonald IA, Amiel SA. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM. Diabetologia, 1995, 38, 1412-1418.
28. Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in ptients with insulin-dependent diabetes mellitus. N Engl Med, 1995, 333, 1726-31.
29. McLeod KM, Gold AE, Ebmeier KP, Hepburn DA, Deary IJ, Goodwin GM, Frier BM. The effects of acute hypoglycemia on relative cerebral blood flow distribution in patients with type I (insulin-dependent) diabetes and impaired hypoglycemia awareness. Metabolism, 1996, 45, 974-980.
30. Kumagai AK, Kang YS, Boado RJ, Pardridge WM. Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes, 1995, 44, 1399-1404.
31. Sélam JL, Medlej R, M'Bemba J, Chevalier A, Guyon F, Ashworth L, Slama G. Symptoms, hormones, and glucose fluxes during a gradual hyoglycaemia induced by intraperitoneal vs venous insulin infusion in type I diabetes. Diabetic Medicine, 1995, 12, 1102-1109.
32. Kerr D, Reza M, Smith., Leatherdale BA. Importance of insulin in subjective cognitive, and hormonal responses to hypoglycemia in patients with IDDM. Diabetes, 1991, 40, 1057-62.
33. Davis SN, Goldstein RE, Jacobs J, Price L, Wolfe R, Cherrington AD. The effects of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans. Diabetes, 1993, 42, 263-72.
34. Fanelli CG, Pampanelli S, Epifano L, Rambotti AM, Ciofetta M, Modarelli F, Di Vincenzo A, Annibale B, Lepore M, Lalli C, Del Sindaco P, Brunetti P, Bolli GB. Cognitive roles of insulin and hypoglycaemia on induction neuroendocrine responses to, symptoms of, and deterioration cognitive function in hypoglycaemia in male and femal humans. Diabetologia, 1994, 37, 797-807.
35. Davis SN, Shavers C, Costa F, Mosqueda-Garcia R. Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans. J Clin Invest, 1996, 98, 680-691.
36. Cranston I, Lomas J, Maran A, McDonald I, Amiel SA. Restoration of hypoglycaemia awareness in patients with lone-duration insulin-dependent diabetes. Lancet, 1994, 344, 283-87.
37. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, Di Vincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Perriello G, De Feop P, Santeusanio F, Brunetti P, Bolli GB. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive therapy in IDDM. Diabetologia, 1994, 37, 1265-1276.
38. Pampanelli S, Fanelli C, Lalli C, Ciofeta M, Del Sindaco P, Lepore M, Modarelli E, Rambotti AM, Epifano L, Di Vincenzo A, Bartocci L, Annibale B, Brunetti P, Bolli GB. Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia. Diabetologia, 1996, 39, 677-696.
39. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB. Meticulous prevention of hypoglycemia normalize the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes, 1993, 42, 1683-89.
40. Cox D, Gonder-Frederick L, Polonsky W, Schlundt D, Julian D, Clarke W. A multicenter evaluation of blood glucose awareness training-II. Diabetes Care, 1995, 18, 523-26.
41. Jullien V, Elgrably F, Traynard PY, Slama G, Sélam JL. Evaluation of a structured 4-day educational programme for intensive insulin therapy. Diabetic Medicine, 1997, 14, 000-000.
42. Wiethop BV, Cryer PE. Alanine and terbutaline in treatment of hypoglycemia in IDDM. Diabetes Care, 1993, 16, 1131-36.
43. Wiethop BV, Cryer PE. Glycemic actions of alanine and terbutaline in IDDM : Diabetes Care, 1993, 16, 1124-30.
44. Kerr D, Sherwin RS., Pavalkis F, Fayad PB, Sikorski L, Rife F, Tamborlane WV, During MJ. Effect of caffeine on the recognition of and respnses to hypoglycemia in humans. Ann Intent Med, 1993, 119, 799-804.
45. Hvidberg A, Rasmussen MH, Christensen NJ, Hilsted J. Theophylline enhances glucose recovery after hypoglycemia in healthy man and in type I diabetic patients. Metabolism, 1994, 43, 776-781.
46. Bachelard HS. Current concepts in brain biochemistry and metabolism. EASD 1996 Satellite Symposium, August 30-31, 1996, Bled, Slovenia, p. 6
47. Amiel SA. Potential fuels for cerebral metabolism in vivo. EASD 1996 Satellite Symposium, August 30-31, 1996, Bled, Slovenia, p. 20
48. Johnson WA, Weiner MW. Protective effects of ketogenic diets on signs of hypoglycemia. Diabetes, 1978, 27, 1087-91.
49. Maran A, Cranston I, Lomas J, McDonald I, Amiel S. Protection by lactate of cerebral function during hypoglycaemia. Lancet, 1994, 343, 16-20.
50. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes, 1994, 43, 1311-1317.
51. King P, Parkin H, McDonald IA, Barber C, Tattersall RB. The effect of intravenous lactate on cerebral function during hypoglycaemia. Diabetic Medicine, 1997, 14, 19-28.